DNA damage chemotherapeutic drugs suppress basal-like breast cancer growth by down-regulating the transcription of the FOXO1-KLF5 axis

Qiuxia Cui; Jian Sun; Jingping Yuan; Juanjuan Li; Chuanyu Yang; Guangshi Du; Chengang Zhou; Pu Qiu; Jidong Gao; Yuanqi Zhang; Dewei Jiang; Ceshi Chen

doi:10.1016/j.gendis.2023.03.028

您当前的位置：

首页 >

文章列表页 >

DNA damage chemotherapeutic drugs suppress basal-like breast cancer growth by down-regulating the transcription of the FOXO1-KLF5 axis

Rapid Communications | 更新时间：2024-02-04

- DNA damage chemotherapeutic drugs suppress basal-like breast cancer growth by down-regulating the transcription of the FOXO1-KLF5 axis
- DNA damage chemotherapeutic drugs suppress basal-like breast cancer growth by down-regulating the transcription of the FOXO1-KLF5 axis
- Genes & Diseases 2024年1卷第1期页码：91-94
- 作者机构：
  
  1. Affiliated Hospital of Guangdong Medical University Science & Technology of China,Guangdong,Zhanjiang,China,524000
  2. Department of Breast Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital and Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College,Guangdong,Shenzhen,China,518116
  3. Key Laboratory of Animal Models and Human Disease Mechanisms of the Chinese Academy of Sciences and Yunnan Province, Kunming Institute of Zoology, Chinese Academy of Sciences,Yunnan,Kunming,China,650223
  4. Department of Breast Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,China,100021
  5. Department of Pathology, Renmin Hospital of Wuhan University,Hubei,Wuhan,China,430060
  6. Department of Breast and Thyroid Surgery, Renmin Hospital of Wuhan University,Hubei,Wuhan,China,430060
  7. Translational Medicine Research Center of Guizhou Medical University,Guizhou,Guiyang,China,550025
  8. Yunnan Cancer Hospital and the Third Affiliated Hospital of Kunming Medical University and Yunnan Cancer Center,Yunnan,Kunming,China,650500
  9. Academy of Biomedical Engineering, Kunming Medical University,Yunnan,Kunming,China,650500
- 作者简介：
- 基金信息：
- DOI：10.1016/j.gendis.2023.03.028
  中图分类号：
- 纸质出版日期：2024，
  
  网络出版日期：2024-1-1，
扫描看全文
DNA damage chemotherapeutic drugs suppress basal-like breast cancer growth by down-regulating the transcription of the FOXO1-KLF5 axis[J]. Genes & Diseases, 2024,1(1):91-94.

Qiuxia Cui, Jian Sun, Jingping Yuan, et al. DNA damage chemotherapeutic drugs suppress basal-like breast cancer growth by down-regulating the transcription of the FOXO1-KLF5 axis[J]. Genes & Diseases, 2024,1(1):91-94.
DNA damage chemotherapeutic drugs suppress basal-like breast cancer growth by down-regulating the transcription of the FOXO1-KLF5 axis[J]. Genes & Diseases, 2024,1(1):91-94. DOI： 10.1016/j.gendis.2023.03.028.

Qiuxia Cui, Jian Sun, Jingping Yuan, et al. DNA damage chemotherapeutic drugs suppress basal-like breast cancer growth by down-regulating the transcription of the FOXO1-KLF5 axis[J]. Genes & Diseases, 2024,1(1):91-94. DOI： 10.1016/j.gendis.2023.03.028.

摘要

Abstract

关键词

Keywords

references

1 W.D. Foulkes, I.E. Smith, J.S. Reis-FilhoTriple-negative breast cancer N Engl J Med, 363 (20) (2010), pp. 1938-1948

2 C.H. Chen, N. Yang, Y. Zhang, et al.Inhibition of super enhancer downregulates the expression of KLF5 in basal-like breast cancers Int J Biol Sci, 15 (8) (2019), pp. 1733-1742

3 M.C.W. van den Berg, B.M.T. BurgeringIntegrating opposing signals toward Forkhead box O Antioxidants Redox Signal, 14 (4) (2011), pp. 607-621

4 J.M. Yu, W. Sun, Z.H. Wang, et al.TRIB3 supports breast cancer stemness by suppressing FOXO1 degradation and enhancing SOX2 transcription Nat Commun, 10 (1) (2019), p. 5720

5 I.D. Kyriazis, M. Hoffman, L. Gaignebet, et al.KLF5 is induced by FOXO1 and causes oxidative stress and diabetic cardiomyopathy Circ Res, 128 (3) (2021), pp. 335-357

查看原文

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

暂无数据